Status:
COMPLETED
Effect of Two Different Doses of Intrathecal Dexmedetomidine as Adjuvant in Elderly Patients Undergoing HoLEP
Lead Sponsor:
Mansoura University
Conditions:
Transurethral Resection of Prostate
Eligibility:
MALE
60-85 years
Phase:
EARLY_PHASE1
Brief Summary
Transurethral resection of the prostate (TURP) is the most common Surgical intervention for elderly patients with benign prostatic hyperplasia. Spinal anesthesia is the technique of choice in TURP.Int...
Detailed Description
The study hypothesis is that there may be a dose dependent prolongation of dexametomedine with escalating doses of intrathecal dexmedetomidine.In this study we tried to find out the optimum safe dose ...
Eligibility Criteria
Inclusion
- Elderly patients undergoing transurtheral resection of Prostate.
- American Society of Anesthesiologists (ASA) physical status I/II
Exclusion
- Any contraindication to subarachnoid block.
- On chronic analgesic therapy.
- Patients refuse to contribute in the study.
- Cognitive impairment.
- Not able to understand numerical rating pain scale (NRS). 6.-Significant comorbid conditions like uncontrolled hypertension, congestive heart failure myocardial infarction in the past 6 months..
Key Trial Info
Start Date :
May 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05351489
Start Date
May 30 2022
End Date
December 31 2024
Last Update
May 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and nephrology center
Al Mansurah, Dakahlia Governorate, Egypt, 050